A Shocking Shot: China's Latest Vaccine Forgery More Problematic Than Ever
Executive Summary
Just when a fragile sector has barely regained its footing, a new vaccine scandal in China has and come into the national spotlight, and some underlying issues this time could go beyond distribution negligence and regulatory non-compliance.
You may also be interested in...
Real-Time Manufacturing Volume Reporting Could Help Prevent Drug Shortages, Woodcock Tells Congress
If the US FDA could track production, it could anticipate shortages – and national security threats from countries like China.
Unbearable Lightness? China Levies Record $1.3bn Fine Amid Vaccine Scandal
Record-breaking fine slapped on scandal-hit domestic vaccine maker in China has some wondering if the tide of opinion may be turning against private companies.
Art Of War: Why Pharma Must Do Digital Dance In China
“Winning the war without fighting. Using five types of fire attacks.” Sounds familiar? Sun Tzu's 2,000 year-old wisdom on the art of war is echoing down the ages, and winning in China today means that pharma needs to embrace a digital strategy more than ever before.